ANNE ABWOM: Open Payments
NPI 1588419311 · COATESVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 28 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $331 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $195 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Alkermes, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, INGREZZA, CAPLYTA, VRAYLAR, Auvelity, ARISTADA, ABILIFY MAINTENA, REXULTI.
Industry payments across PA — which companies pay providers there.
